Category: Supply Chain

ASCs continue to face supply chain challenges: Here's how to improve them

Challenges in the healthcare supply chain have been exacerbated over the last three years by the COVID-19 pandemic, which has increased costs and decreased product availability worldwide. 

Former Baxter CFO to join GE Healthcare

GE Healthcare has selected James Saccara, a top executive at Baxter International, to serve as vice president and CFO, effective June 1. 

FDA: Healthcare supply chain troubles existed before COVID-19, and they could get worse

While COVID-19 caused the largest disruption to supply chains across industries, officials at the FDA’s Center for Devices and Radiological Health said some of the issues within the healthcare supply chain existed before the pandemic. Now, experts say,…

UPS to open 7 healthcare logistics facilities to aid supply chain

UPS Healthcare announced plans to open seven new locations in addition to its existing 70 facilities in the coming months, company leaders said during the April 25 Q1 2023 earnings meeting. 

COVID-19 loosening its grip on health systems' supply chains: WHO

Hospitals and health systems are recovering from pandemic-induced supply issues, the World Health Organization said May 2. 

The ASC obstacle that is 'literally out of control,' according to a CEO

Jeremy Riley, CEO of Titusville, Fla.-based GML Healthcare Consulting, joined Becker’s to discuss the disruptions of the ASC industry. 

The untapped supply chain talent pool: How 1 VP gets the community involved

For Jeremy Strong, Chicago-based Rush University System for Health’s vice president for supply chain operations, the ability to affect both patients and the community is one of the most rewarding parts of hospital supply chain.

AHA: Supply chain won't return to 'normal' anytime soon, but here's what you can do

The American Hospital Association argues that the healthcare supply chain is not going to be back to “normal” anytime soon, despite estimates that still project its growth.

Prostate cancer drug shortage may resolve in late 2023, company says

Pluvicto, a prostate cancer drug manufactured by Novartis, approved by the FDA in March 2022, has been in short supply for several months due to issues with delivery and manufacturing — but the shortage may be ending, according to NBC News.

1 death, 4 injuries precede recall of 1K Avanos catheters

Avanos Medical recalled 1,000 catheters April 21 with a Class I warning, the most serious type, because of cracked parts that can increase the risk of delayed or prevented ventilation. One death and four injuries have been reported.